Microrna-mediated down-regulation of apoptosis signal-regulating kinase 1 (ASK1) attenuates the apoptosis of human mesenchymal stem cells (MSCs) transplanted into infarcted heart

International Journal of Molecular Sciences

Volumn 17, Issue 10, 2016, Pages

  Lee, Chang Youn ^a   Shin, Sunhye ^a   Lee, Jiyun ^a   Seo, Hyang Hee ^a   Lim, Kyu Hee ^b   Kim, Hyemin ^a   Choi, Jung Won ^c   Kim, Sang Woo ^c   Lee, Seahyung ^c   Lim, Soyeon ^c   Hwang, Ki Chul ^c  

^a Yonsei University   (South Korea)

^b Chonbuk National University   (South Korea)

^c Catholic Kwandong University   (South Korea)

Author keywords

Adipose derived stem cell (ASC); Apoptosis signal regulating kinase 1 (ASK1); Mesenchymal stem cells (MSCs); MicroRNA 301a; Myocardial infarction (MI); Reactive oxygen species (ROS)

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; LIPOCORTIN 5; MICRORNA; MICRORNA 301A; PROTEIN P53; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; MAP3K5 PROTEIN, HUMAN; MIRN301 MICRORNA, HUMAN; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; ADIPOSE DERIVED STEM CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; HEART INFARCTION; HUMAN; HUMAN CELL; HYPOXIA; LUCIFERASE ASSAY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUNEL ASSAY; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL LINE; CYTOLOGY; DISEASE MODEL; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; PROCEDURES; RNA INTERFERENCE;

ANIMALS; APOPTOSIS; CELL LINE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HUMANS; MAP KINASE KINASE KINASE 5; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICRORNAS; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84992126183     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17101752     Document Type: Article

References (38)

1. Baig, M.K.; Mahon, N.; McKenna, W.J.; Caforio, A.L.; Bonow, R.O.; Francis, G.S.; Gheorghiade, M. The pathophysiology of advanced heart failure. Heart Lung 1999, 28, 87–101.
2. Nelson, D.M.; Ma, Z.; Fujimoto, K.L.; Hashizume, R.; Wagner, W.R. Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges. Acta Biomater. 2011, 7, 1–15.
3. Penn, M.S.; Mangi, A.A. Genetic enhancement of stem cell engraftment, survival, and efficacy. Circ. Res. 2008, 102, 1471–1482.
4. Nekanti, U.; Rao, V.B.; Bahirvani, A.G.; Jan, M.; Totey, S.; Ta, M. Long-term expansion and pluripotent marker array analysis of wharton's jelly-derived mesenchymal stem cells. Stem Cells Dev. 2010, 19, 117–130.
5. Pittenger, M.F.; Mackay, A.M.; Beck, S.C.; Jaiswal, R.K.; Douglas, R.; Mosca, J.D.; Moorman, M.A.; Simonetti, D.W.; Craig, S.; Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284, 143–147.
6. Zhu, Y.; Liu, T.; Song, K.; Fan, X.; Ma, X.; Cui, Z. Adipose-derived stem cell: A better stem cell than BMSC. Cell Biochem. Funct. 2008, 26, 664–675.
7. Mylotte, L.A.; Duffy, A.M.; Murphy, M.; O'Brien, T.; Samali, A.; Barry, F.; Szegezdi, E. Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment. Stem Cells 2008, 26, 1325–1336.
8. Sadan, O.; Melamed, E.; Offen, D. Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases. Expert Opin. Biol. Ther. 2009, 9, 1487–1497.
9. Gimble, J.M.; Katz, A.J.; Bunnell, B.A. Adipose-derived stem cells for regenerative medicine. Circ. Res. 2007, 100, 1249–1260.
10. Chen, L.; Qin, F.; Ge, M.; Shu, Q.; Xu, J. Application of adipose-derived stem cells in heart disease. J. Cardiovasc. Transl. Res. 2014, 7, 651–663.
11. Ichijo, H.; Nishida, E.; Irie, K.; ten Dijke, P.; Saitoh, M.; Moriguchi, T.; Takagi, M.; Matsumoto, K.; Miyazono, K.; Gotoh, Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997, 275, 90–94.
12. Gotoh, Y.; Cooper, J.A. Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-α signal transduction. J. Biol. Chem. 1998, 273, 17477–17482.
13. Tobiume, K.; Matsuzawa, A.; Takahashi, T.; Nishitoh, H.; Morita, K.; Takeda, K.; Minowa, O.; Miyazono, K.; Noda, T.; Ichijo, H. ASK1 is required for sustained activations of JNK/p38 map kinases and apoptosis. EMBO Rep. 2001, 2, 222–228.
14. Liu, Q.; Sargent, M.A.; York, A.J.; Molkentin, J.D. ASK1 regulates cardiomyocyte death but not hypertrophy in transgenic mice. Circ. Res. 2009, 105, 1110–1117.
15. Hayakawa, Y.; Hirata, Y.; Sakitani, K.; Nakagawa, H.; Nakata, W.; Kinoshita, H.; Takahashi, R.; Takeda, K.; Ichijo, H.; Maeda, S.; et al. Apoptosis signal-regulating kinase-1 inhibitor as a potent therapeutic drug for the treatment of gastric cancer. Cancer Sci. 2012, 103, 2181–2185.
16. Li, Z.; Rana, T.M. Therapeutic targeting of micrornas: Current status and future challenges. Nat. Rev. Drug Discov. 2014, 13, 622–638.
17. Yang, H.; Kong, W.; He, L.; Zhao, J.J.; O'Donnell, J.D.; Wang, J.; Wenham, R.M.; Coppola, D.; Kruk, P.A.; Nicosia, S.V.; et al. Microrna expression profiling in human ovarian cancer: Mir-214 induces cell survival and cisplatin resistance by targeting pten. Cancer Res. 2008, 68, 425–433.
18. Chang, W.; Lee, C.Y.; Park, J.H.; Park, M.S.; Maeng, L.S.; Yoon, C.S.; Lee, M.Y.; Hwang, K.C.; Chung, Y.A. Survival of hypoxic human mesenchymal stem cells is enhanced by a positive feedback loop involving mir-210 and hypoxia-inducible factor 1. J. Vet. Sci. 2013, 14, 69–76.
19. Guo, S.; Lu, J.; Schlanger, R.; Zhang, H.; Wang, J.Y.; Fox, M.C.; Purton, L.E.; Fleming, H.H.; Cobb, B.; Merkenschlager, M.; et al. Microrna mir-125a controls hematopoietic stem cell number. Proc. Natl. Acad. Sci. USA 2010, 107, 14229–14234.
20. Hayakawa, R.; Hayakawa, T.; Takeda, K.; Ichijo, H. Therapeutic targets in the ASK1-dependent stress signaling pathways. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2012, 88, 434–453.
21. Tobiume, K.; Saitoh, M.; Ichijo, H. Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer. J. Cell. Physiol. 2002, 191, 95–104.
22. Powers, S.K.; Kavazis, A.N.; McClung, J.M. Oxidative stress and disuse muscle atrophy. J. Appl. Physiol. 2007, 102, 2389–2397.
23. Zhang, R.; Al-Lamki, R.; Bai, L.; Streb, J.W.; Miano, J.M.; Bradley, J.; Min, W. Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner. Circ. Res. 2004, 94, 1483–1491.
24. Soga, M.; Matsuzawa, A.; Ichijo, H. Oxidative stress-induced diseases via the ask1 signaling pathway. Int. J. Cell Biol. 2012, 2012, 439587.
25. Guo, X.; Harada, C.; Namekata, K.; Matsuzawa, A.; Camps, M.; Ji, H.; Swinnen, D.; Jorand-Lebrun, C.; Muzerelle, M.; Vitte, P.A.; et al. Regulation of the severity of neuroinflammation and demyelination by tlr-ASK1-p38 pathway. EMBO Mol. Med. 2010, 2, 504–515.
26. Bogoyevitch, M.A.; Ngoei, K.R.; Zhao, T.T.; Yeap, Y.Y.; Ng, D.C. C-jun n-terminal kinase (JNK) signaling: Recent advances and challenges. Biochim. Biophys. Acta 2010, 1804, 463–475.
27. Peifer, C.; Wagner, G.; Laufer, S. New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 map kinase. Curr. Top. Med. Chem. 2006, 6, 113–149.
28. Kaltschmidt, B.; Kaltschmidt, C.; Hofmann, T.G.; Hehner, S.P.; Droge, W.; Schmitz, M.L. The pro- or anti-apoptotic function of nf-kappab is determined by the nature of the apoptotic stimulus. Eur. J. Biochem. 2000, 267, 3828–3835.
29. Matsushita, H.; Morishita, R.; Nata, T.; Aoki, M.; Nakagami, H.; Taniyama, Y.; Yamamoto, K.; Higaki, J.; Yasufumi, K.; Ogihara, T. Hypoxia-induced endothelial apoptosis through nuclear factor-κB (NF-κB)-mediated Bcl-2 suppression: In vivo evidence of the importance of NF-κB in endothelial cell regulation. Circ. Res. 2000, 86, 974–981.
30. Aoki, M.; Nata, T.; Morishita, R.; Matsushita, H.; Nakagami, H.; Yamamoto, K.; Yamazaki, K.; Nakabayashi, M.; Ogihara, T.; Kaneda, Y. Endothelial apoptosis induced by oxidative stress through activation of NF-κB: Antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 2001, 38, 48–55.
31. Munoz, J.L.; Bliss, S.A.; Greco, S.J.; Ramkissoon, S.H.; Ligon, K.L.; Rameshwar, P. Delivery of functional anti-mir-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity. Mol. Ther. Nucleic Acids 2013, 2, e126.
32. Katakowski, M.; Buller, B.; Zheng, X.; Lu, Y.; Rogers, T.; Osobamiro, O.; Shu, W.; Jiang, F.; Chopp, M. Exosomes from marrow stromal cells expressing mir-146b inhibit glioma growth. Cancer Lett. 2013, 335, 201–204.
33. Song, C.L.; Liu, B.; Diao, H.Y.; Shi, Y.F.; Zhang, J.C.; Li, Y.X.; Liu, N.; Yu, Y.P.; Wang, G.; Wang, J.P.; et al. Down-regulation of microrna-320 suppresses cardiomyocyte apoptosis and protects against myocardial ischemia and reperfusion injury by targeting IGF-1. Oncotarget 2016.
34. Jiang, W.L.; Zhang, Y.F.; Xia, Q.Q.; Zhu, J.; Yu, X.; Fan, T.; Wang, F. MicroRNA-19a regulates lipopolysaccharide-induced endothelial cell apoptosis through modulation of apoptosis signal-regulating kinase 1 expression. BMC Mol. Biol. 2015, 16, 11.
35. Patel, N.; Tahara, S.M.; Malik, P.; Kalra, V.K. Involvement of mir-30c and mir-301a in immediate induction of plasminogen activator inhibitor-1 by placental growth factor in human pulmonary endothelial cells. Biochem. J. 2011, 434, 473–482.
36. Wynn, T.A.; Ramalingam, T.R. Mechanisms of fibrosis: Therapeutic translation for fibrotic disease. Nat. Med. 2012, 18, 1028–1040.
37. Gomez, I.G.; Nakagawa, N.; Duffield, J.S. Micrornas as novel therapeutic targets to treat kidney injury and fibrosis. Am. J. Physiol. Ren. Physiol. 2016, 310, F931–F944.
38. Lan, W.; Chen, S.; Tong, L. MicroRNA-215 regulates fibroblast function: Insights from a human fibrotic disease. Cell Cycle 2015, 14, 1973–1984.